35
Growth Score in past quarter
pts
Heat Score 35 in past quarter
25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1012938
TomegaVax is developing cures for AIDS, malaria, tuberculosis, herpes, papillomavirus and hepatitis.
About the Company
TomegaVax Inc. is an immunotherapy company that applies a game-changing vaccine technology platform to areas of unmet medical need. The company is focused on the preclinical and clinical development of vaccines and immunotherapies for chronic and recurring viral infections including Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV),
Hepatitis B Virus (HBV) and Herpes Simplex Virus (HSV).
